Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients Paracentesis con infusión de albumina en el tratamiento de la ascitis a tensión en pacientes cirróticos.
Author
dc.contributor.author
Chesta,
Author
dc.contributor.author
Brahm Barril, Javier
Author
dc.contributor.author
Latorre, Claudio
Author
dc.contributor.author
Gidi,
Author
dc.contributor.author
Hurtado, Sergio
Author
dc.contributor.author
Antezana,
Author
dc.contributor.author
Novoa Novoa, Mónica
Author
dc.contributor.author
Velasco,
Admission date
dc.date.accessioned
2019-01-29T14:49:24Z
Available date
dc.date.available
2019-01-29T14:49:24Z
Publication date
dc.date.issued
1990
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 118, Issue 8, 2018, Pages 874-880
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160850
Abstract
dc.description.abstract
We randomized 31 cirrhotic patients with tense ascites to a Group A receiving only diuretic therapy (spironolactone, furosemide, n = 14) or a Group B treated with paracentesis and intravenous albumin infusion (n = 17). Ascites was eliminated in 88% of patients in Group B compared to 57% of patients in Group A (p < 0.05). Complications developed in 4 patients in Group A and 2 patients in Group B. Paracentesis was associated to a mild and transient reduction in mean arterial pressure and a significant rise in urinary output. Duration of hospital stay was 5 +/- 3 days in Group B and 22 +/- 6 in Group A (p < 0.001). Survival and likelihood of readmission for ascites was similar in both groups. Our results suggest that paracentesis plus intravenous albumin infusion is a fast, safe and effective therapy for tense ascites in cirrhotic patients.
Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients Paracentesis con infusión de albumina en el tratamiento de la ascitis a tensión en pacientes cirróticos.